Technology platforms

The Center for Immuno-Oncology established the Tissue Biomarker Laboratory to assist investigators at Dana-Farber Cancer Institute (DFCI) and its partners in analyzing the immune microenvironment of tumors. The Lab is equipped with the latest technology for detecting tissue biomarkers and determining cellular phenotypes with formalin-fixed paraffin embedded (FFPE) tissue biopsy samples.

The goal of the Tissue Biomarker Laboratory is to provide researchers with access to the latest innovations in immune monitoring in a quality-controlled setting. The Lab is committed to discovering and exploring essential and translational approaches in immune-oncology and offers technical support and scientific advice to investigators at DFCI and its partners who are interested in performing clinical studies related to cancer immunotherapies. The Lab can provide data generation for clinical trials across multiple disease centers, as well as the necessary expertise to design and develop assays related to cancer immunology biomarkers.